Oxygen Is Life – Particularly for COVID-19 Treatment – New Taskforce Aims To Raise US$1.6 billion For Supplies In Low- and Middle-Income Countries 25/02/2021 Raisa Santos A new COVID-19 Oxygen Emergency Taskforce has been created in response to the dearth of sustainable oxygen supplies in low- and middle-income countries (LMICs) – and its critical importance for treatment of COVID-19. Co-created by Unitaid and Wellcome Trust in partnership with the WHO and a range of other global public health agencies, the taskforce, […] Continue reading -> Some Countries Ease Lockdowns, But Others Battle New COVID-19 Surges 23/02/2021 Raisa Santos & Kerry Cullinan The United Kingdom, Switzerland, Israel and Turkey are cautiously reopening businesses and relaxing limits on gatherings and travel as COVID-19 cases declined both globally and within these countries. However, parts of France, the Czech Republic, and Sweden are preparing for harder lockdown measures as their cases surge in contrast to worldwide trends. As of 23 […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Secrecy Surrounds the Start of Rwanda’s COVID-19 Vaccination Roll-out 19/02/2021 Esther Nakkazi Rwanda started vaccinating health workers against COVID-19 on Monday, but there is confusion about which vaccine it is using or where it has got it from. A local media report said that the Moderna vaccine was being used while the BBC reported that the Pfizer/ BioNtech vaccine was being used. Meanwhile, a source told Health […] Continue reading -> Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Some Countries Ease Lockdowns, But Others Battle New COVID-19 Surges 23/02/2021 Raisa Santos & Kerry Cullinan The United Kingdom, Switzerland, Israel and Turkey are cautiously reopening businesses and relaxing limits on gatherings and travel as COVID-19 cases declined both globally and within these countries. However, parts of France, the Czech Republic, and Sweden are preparing for harder lockdown measures as their cases surge in contrast to worldwide trends. As of 23 […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Secrecy Surrounds the Start of Rwanda’s COVID-19 Vaccination Roll-out 19/02/2021 Esther Nakkazi Rwanda started vaccinating health workers against COVID-19 on Monday, but there is confusion about which vaccine it is using or where it has got it from. A local media report said that the Moderna vaccine was being used while the BBC reported that the Pfizer/ BioNtech vaccine was being used. Meanwhile, a source told Health […] Continue reading -> Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Secrecy Surrounds the Start of Rwanda’s COVID-19 Vaccination Roll-out 19/02/2021 Esther Nakkazi Rwanda started vaccinating health workers against COVID-19 on Monday, but there is confusion about which vaccine it is using or where it has got it from. A local media report said that the Moderna vaccine was being used while the BBC reported that the Pfizer/ BioNtech vaccine was being used. Meanwhile, a source told Health […] Continue reading -> Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Secrecy Surrounds the Start of Rwanda’s COVID-19 Vaccination Roll-out 19/02/2021 Esther Nakkazi Rwanda started vaccinating health workers against COVID-19 on Monday, but there is confusion about which vaccine it is using or where it has got it from. A local media report said that the Moderna vaccine was being used while the BBC reported that the Pfizer/ BioNtech vaccine was being used. Meanwhile, a source told Health […] Continue reading -> Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Health Diplomacy In The COVID-19 Era – Can Failure Usher In A New Era of Success? 22/02/2021 Svĕt Lustig Vijay More than a year into the world’s largest global health emergency, health diplomats have fought hard to ensure that every country across the globe secures access to lifesaving coronavirus health products, including vaccines, treatments, and diagnostics. That has not happened yet, given that 80% of countries that are now rolling out vaccines are either high-income […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Secrecy Surrounds the Start of Rwanda’s COVID-19 Vaccination Roll-out 19/02/2021 Esther Nakkazi Rwanda started vaccinating health workers against COVID-19 on Monday, but there is confusion about which vaccine it is using or where it has got it from. A local media report said that the Moderna vaccine was being used while the BBC reported that the Pfizer/ BioNtech vaccine was being used. Meanwhile, a source told Health […] Continue reading -> Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Secrecy Surrounds the Start of Rwanda’s COVID-19 Vaccination Roll-out 19/02/2021 Esther Nakkazi Rwanda started vaccinating health workers against COVID-19 on Monday, but there is confusion about which vaccine it is using or where it has got it from. A local media report said that the Moderna vaccine was being used while the BBC reported that the Pfizer/ BioNtech vaccine was being used. Meanwhile, a source told Health […] Continue reading -> Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Secrecy Surrounds the Start of Rwanda’s COVID-19 Vaccination Roll-out 19/02/2021 Esther Nakkazi Rwanda started vaccinating health workers against COVID-19 on Monday, but there is confusion about which vaccine it is using or where it has got it from. A local media report said that the Moderna vaccine was being used while the BBC reported that the Pfizer/ BioNtech vaccine was being used. Meanwhile, a source told Health […] Continue reading -> Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Secrecy Surrounds the Start of Rwanda’s COVID-19 Vaccination Roll-out 19/02/2021 Esther Nakkazi Rwanda started vaccinating health workers against COVID-19 on Monday, but there is confusion about which vaccine it is using or where it has got it from. A local media report said that the Moderna vaccine was being used while the BBC reported that the Pfizer/ BioNtech vaccine was being used. Meanwhile, a source told Health […] Continue reading -> Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Crime And (No) Punishment: Why Africa’s Ports Are Vulnerable To Counterfeit COVID Vaccines 18/02/2021 Darren Taylor/Bhekisisa MOMBASA, KENYA – Africa’s ports are vulnerable to crime and corruption. Now they’re set to be the main thoroughfare for COVID vaccines entering the continent. Here’s why we need a better strategy to curb potential counterfeits coming through. Black-green tears of moss streak the facades of once-white buildings. The city is a maze of narrow […] Continue reading -> Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> Posts navigation Older postsNewer posts